Effect of HLA Matching on Pediatric Renal Transplant Graft Survival in China

Area of Science:

• Immunogenetics
• Transplantation immunology
• Pediatric nephrology

Background:

• Kidney transplantation (KTX) is a primary treatment for pediatric end-stage renal disease (ESRD).
• The impact of human leukocyte antigen (HLA) mismatching on pediatric KTX graft survival requires further clarification.

Purpose of the Study:

• To investigate the association between HLA amino acid residue mismatches and graft survival in pediatric kidney transplant recipients.
• To determine the specific HLA loci and mismatch thresholds that influence graft outcomes.

Main Methods:

• Analysis of HLA-A, -B, and -DR loci residue mismatches in 36 pediatric patients with complete donor-recipient HLA data.
• Separate assessment of single-locus and combined HLA-A+B+DR loci residue mismatches on graft survival probability.

Main Results:

• No significant association was found between HLA-A, -B, or -DR residue mismatches and kidney graft survival.
• A significant increase in the relative risk of graft rejection was observed with 3 to 4 mismatches at the combined HLA-A+B+DR loci (P = .0292).

Conclusions:

• While individual HLA loci mismatches may not significantly affect outcomes, combined HLA-A+B+DR residue mismatches are critical predictors of graft survival in pediatric KTX.
• Minimizing mismatches at HLA-A, -B, and -DR loci may be crucial for improving long-term graft function in pediatric kidney transplant patients.